{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:09:18Z","timestamp":1792789758242,"version":"4.5.0"},"reference-count":52,"publisher":"Bioscientifica","issue":"6","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":256,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Orthobiologics (OBs) have seen a constant increase in the number of available therapies and their clinical applications. Existing therapies can be categorized into blood-based (e.g., platelet-rich plasma (PRP)) and tissue\/cell-based (e.g. mesenchymal stromal cells) approaches. While the popularity of OBs continues to grow, their diverse natures create unique challenges for the establishment of evidence-based guidelines. PRP has been reported by meta-analyses to increase patient-reported outcomes for conditions such as knee osteoarthritis (KOA), lateral epicondylitis and plantar fasciitis. However, the randomized controlled trials (RCTs) included often exhibit a high risk of bias due to the heterogeneity in the PRP preparation protocols and accompanying measures as well as inconsistent trial quality. The development pipeline of cell\/tissue-based therapies is typically longer and more cost-intensive than that of blood-based therapies. Nevertheless, several products have demonstrated clinical safety. While some RCTs and meta-analyses on the outcome of cell\/tissue-based therapies exist, their number is considerably lower than that of blood-based therapies and they focus mainly on KOA, with limited evidence on other orthopedic indications. Orthopedic societies such as ESSKA and AAOS have taken on the challenge of developing guidelines for OBs by combining high-level synthesized evidence with expert consensus. Patient stratification strategies represent a promising key to unlocking the full potential of OBs and are currently being investigated in ongoing studies. Further efforts to establish guidelines for the use of OBs should focus on developing frameworks for clinical trials and their reporting, alongside standardized protocols for the preparation, application and accompanying measures of OB therapies.<\/jats:p>","DOI":"10.1530\/eor-2025-0069","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T07:53:34Z","timestamp":1748937214000},"page":"345-351","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-16","source":"Crossref","is-referenced-by-count":11,"title":["Evidence-based guidelines on orthobiologics"],"prefix":"10.1530","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0727-4680","authenticated-orcid":true,"given":"Tobias","family":"Winkler","sequence":"first","affiliation":[{"name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Center for Musculoskeletal Surgery (CMSC) 1 , ,","place":["Berlin, Germany"]},{"name":"Berlin Institute of Health (BIH) at Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Julius Wolff Institute (JWI) 2 , ,","place":["Berlin, Germany"]},{"name":"Berlin Institute of Health (BIH) at Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT) 3 , ,","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Oehme","sequence":"additional","affiliation":[{"name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Center for Musculoskeletal Surgery (CMSC) 1 , ,","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hildebrandt","sequence":"additional","affiliation":[{"name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Center for Musculoskeletal Surgery (CMSC) 1 , ,","place":["Berlin, Germany"]},{"name":"Berlin Institute of Health (BIH) at Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Julius Wolff Institute (JWI) 2 , ,","place":["Berlin, Germany"]},{"name":"Berlin Institute of Health (BIH) at Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT) 3 , ,","place":["Berlin, Germany"]},{"name":"Berlin Institute of Health (BIH) at Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charit\u00e9 Junior Clinician Scientist Program 4 , ,","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azzurra","family":"Paolucci","sequence":"additional","affiliation":[{"name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Center for Musculoskeletal Surgery (CMSC) 1 , ,","place":["Berlin, Germany"]},{"name":"Berlin Institute of Health (BIH) at Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT) 3 , ,","place":["Berlin, Germany"]},{"name":"Universit\u00e0 degli Studi Alma Mater Studiorum di Bologna, IRCCS Istituto Ortopedico Rizzoli di Bologna 5 , ,","place":["Bologna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9848-778X","authenticated-orcid":false,"given":"Lorenz","family":"Pichler","sequence":"additional","affiliation":[{"name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Center for Musculoskeletal Surgery (CMSC) 1 , ,","place":["Berlin, Germany"]},{"name":"Medical University of Vienna, Department of Orthopedics and Trauma-Surgery 6 , ,","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"2026070711162185300_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/039139888701000111","article-title":"A new technique for hemodilution, preparation of autologous platelet-rich plasma and intraoperative blood salvage in cardiac surgery","volume":"10","author":"Ferrari","year":"1987","journal-title":"Int J Artif Organs"},{"key":"2026070711162185300_bib2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2217\/rme-2018-0042","article-title":"A contemporary view of platelet-rich plasma therapies: moving toward refined clinical protocols and precise indications","volume":"13","author":"Andia","year":"2018","journal-title":"Regen Med"},{"key":"2026070711162185300_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.901317","article-title":"Gene therapy in orthopaedics: progress and challenges in pre-clinical development and translation","volume":"10","author":"Watson-Levings","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"2026070711162185300_bib4","author":"Orthobiologics Market"},{"key":"2026070711162185300_bib5","article-title":"Utilization of Orthobiologics by sports medicine physicians: a survey-based study","volume":"5","author":"Noback","year":"2021","journal-title":"J Am Acad Orthop Surg Glob Res Rev"},{"key":"2026070711162185300_bib6","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1177\/03635465211037343","article-title":"Current trends in Orthobiologics: an 11-year review of the orthopaedic literature","volume":"50","author":"Obana","year":"2022","journal-title":"Am J Sports Med"},{"key":"2026070711162185300_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/pmrj.13271","article-title":"Postprocedure protocols after intraarticular orthobiologic injections \u2013 a scoping review","volume":"17","author":"Kruse","year":"2024","journal-title":"PM R"},{"key":"2026070711162185300_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mporth.2024.12.001","article-title":"Intra-articular injections for the management of knee osteoarthritis","volume":"39","author":"Super","year":"2025","journal-title":"Orthop Trauma"},{"key":"2026070711162185300_bib9","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2106\/JBJS.16.01374","article-title":"A call for standardization in platelet-rich plasma preparation protocols and composition reporting: a systematic review of the clinical orthopaedic literature","volume":"99","author":"Chahla","year":"2017","journal-title":"J Bone Joint Surg Am"},{"key":"2026070711162185300_bib10","first-page":"In press","article-title":"Experts achieve consensus on a majority of statements regarding ethics, transparency, regulation and best practices for the use of Orthobiologics","author":"Gilat","year":"2025","journal-title":"Arthroscopy"},{"key":"2026070711162185300_bib11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ksa.12077","article-title":"The use of injectable Orthobiologics for knee osteoarthritis: a European ESSKA-ORBIT consensus. Part 1-blood-derived products (platelet-rich plasma)","volume":"32","author":"Laver","year":"2024","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"2026070711162185300_bib12","first-page":"In press","article-title":"Cell-based therapies have disease-modifying effects on osteoarthritis in animal models: a systematic review by the ESSKA Orthobiologic Initiative. Part 3: umbilical cord, placenta, and other sources for cell-based injectable therapies","author":"Sourugeon","year":"2024","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"2026070711162185300_bib13","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.5435\/JAAOS-D-18-00305","article-title":"Optimizing clinical use of biologics in orthopaedic surgery: consensus recommendations from the 2018 AAOS\/NIH U-13 conference","volume":"27","author":"Chu","year":"2019","journal-title":"J Am Acad Orthop Surg"},{"key":"2026070711162185300_bib14","doi-asserted-by":"crossref","first-page":"296","DOI":"10.5435\/JAAOS-D-23-00957","article-title":"American academy of orthopaedic surgeons technology overview summary: platelet-rich plasma (PRP) for knee osteoarthritis","volume":"32","author":"Dubin","year":"2024","journal-title":"J Am Acad Orthop Surg"},{"key":"2026070711162185300_bib15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/09537104.2016.1143922","article-title":"Cytokine, chemokine, and growth factor profile of platelet-rich plasma","volume":"27","author":"Mussano","year":"2016","journal-title":"Platelets"},{"key":"2026070711162185300_bib16","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1902\/jop.2007.060302","article-title":"Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties","volume":"78","author":"El-Sharkawy","year":"2007","journal-title":"J Periodontol"},{"key":"2026070711162185300_bib17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/03635465231192473","article-title":"An update on Orthobiologics: cautious optimism","volume":"52","author":"Nelson","year":"2024","journal-title":"Am J Sports Med"},{"key":"2026070711162185300_bib18","article-title":"Therapeutic uses of platelet-rich plasma (PRP) in sport injuries \u2013 a narrative review","volume":"3","author":"Patil","year":"2024","journal-title":"J Orthopaedic Rep"},{"key":"2026070711162185300_bib19","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1016\/j.arthro.2021.07.003","article-title":"Platelet-rich plasma: fundamentals and clinical applications","volume":"37","author":"Sheean","year":"2021","journal-title":"Arthroscopy"},{"key":"2026070711162185300_bib20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2106\/JBJS.K.00430","article-title":"Platelet-rich plasma differs according to preparation method and human variability","volume":"94","author":"Mazzocca","year":"2012","journal-title":"J Bone Joint Surg Am"},{"key":"2026070711162185300_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.32098\/mltj.01.2014.02","article-title":"Classification of platelet concentrates (platelet-rich plasma-PRP, platelet-rich fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives","volume":"4","author":"Dohan","year":"2014","journal-title":"Muscles Ligaments Tendons J"},{"key":"2026070711162185300_bib22","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2174\/138920112800624283","article-title":"Sports medicine applications of platelet rich plasma","volume":"13","author":"Mishra","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"2026070711162185300_bib23","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.arthro.2012.04.148","article-title":"Platelet-rich plasma: the PAW classification system","volume":"28","author":"DeLong","year":"2012","journal-title":"Arthroscopy"},{"key":"2026070711162185300_bib24","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s12178-018-9527-7","article-title":"Current clinical recommendations for use of platelet-rich plasma","volume":"11","author":"Le","year":"2018","journal-title":"Curr Rev Musculoskelet Med"},{"key":"2026070711162185300_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13018-017-0521-3","article-title":"The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Shen","year":"2017","journal-title":"J Orthop Surg Res"},{"key":"2026070711162185300_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/23259671221086920","article-title":"Effectiveness of platelet-rich plasma for lateral epicondylitis: a systematic review and meta-analysis based on achievement of minimal clinically important difference","volume":"10","author":"Niemiec","year":"2022","journal-title":"Orthop J Sports Med"},{"key":"2026070711162185300_bib27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.fas.2024.02.004","article-title":"Platelet rich plasma therapy versus other modalities for treatment of plantar fasciitis: a systematic review and meta-analysis","volume":"30","author":"Herber","year":"2024","journal-title":"Foot Ankle Surg"},{"key":"2026070711162185300_bib28","doi-asserted-by":"crossref","DOI":"10.2144\/fsoa-2021-0088","article-title":"Autologous conditioned serum applications in the treatment of musculoskeletal diseases: a narrative review","volume":"8","author":"Raeissadat","year":"2022","journal-title":"Future Sci OA"},{"key":"2026070711162185300_bib29","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1302\/2058-5241.6.200040","article-title":"Autologous protein solution: a promising solution for osteoarthritis?","volume":"6","author":"Bin Abd Razak","year":"2021","journal-title":"EFORT Open Rev"},{"key":"2026070711162185300_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/biores.2017.0027","article-title":"An autologous anti-inflammatory protein solution yielded a favorable safety profile and significant pain relief in an open-label pilot study of patients with osteoarthritis","volume":"6","author":"Hix","year":"2017","journal-title":"Biores Open Access"},{"key":"2026070711162185300_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40634-016-0043-7","article-title":"White blood cell concentration correlates with increased concentrations of IL-1ra and improvement in WOMAC pain scores in an open-label safety study of autologous protein solution","volume":"3","author":"King","year":"2016","journal-title":"J Exp Orthop"},{"key":"2026070711162185300_bib32","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1530\/EOR-24-0084","article-title":"Advanced therapies in orthopaedics","volume":"9","author":"Winkler","year":"2024","journal-title":"EFORT Open Rev"},{"key":"2026070711162185300_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.joca.2024.08.014","article-title":"Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomized trials: a systematic review and network meta-analysis","volume":"33","author":"Pereira","year":"2025","journal-title":"Osteoarthr Cartil"},{"key":"2026070711162185300_bib34","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1177\/03635465231179223","article-title":"Clinical efficacy and safety of the intra-articular injection of autologous adipose-derived mesenchymal stem cells for knee osteoarthritis: a phase III, randomized, double-blind, placebo-controlled trial","volume":"51","author":"Kim","year":"2023","journal-title":"Am J Sports Med"},{"key":"2026070711162185300_bib35","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1038\/s41591-023-02632-w","article-title":"Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial","volume":"29","author":"Mautner","year":"2023","journal-title":"Nat Med"},{"key":"2026070711162185300_bib36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1177\/03635465211053893","article-title":"Intra-articular injection of autologous adipose-derived stem cells or stromal vascular fractions: are they effective for patients with knee osteoarthritis? A systematic review with meta-analysis of randomized controlled trials","volume":"51","author":"Kim","year":"2023","journal-title":"Am J Sports Med"},{"key":"2026070711162185300_bib37","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s13018-024-04846-1","article-title":"Transplantation of three mesenchymal stem cells for knee osteoarthritis, which cell and type are more beneficial? a systematic review and network meta-analysis","volume":"19","author":"Chen","year":"2024","journal-title":"J Orthop Surg Res"},{"key":"2026070711162185300_bib38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/s12891-022-05407-5","article-title":"Efficacy of adjuvant treatment for fracture nonunion\/delayed union: a network meta-analysis of randomized controlled trials","volume":"23","author":"Yang","year":"2022","journal-title":"BMC Musculoskelet Disord"},{"key":"2026070711162185300_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0295876","article-title":"Modified Mesenchymal stem cell, platelet-rich plasma, and hyaluronic acid intervention in early stage osteoarthritis: a systematic review, meta-analysis, and meta-regression of arthroscopic-guided intra-articular approaches","volume":"19","author":"Tjandra","year":"2024","journal-title":"PLoS One"},{"key":"2026070711162185300_bib40","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1186\/s12891-024-08004-w","article-title":"Efficacy and safety of high tibial osteotomy combined with platelet-rich plasma for treating knee osteoarthritis: a systematic review and meta-analysis of the Chinese population","volume":"25","author":"Zhang","year":"2024","journal-title":"BMC Musculoskelet Disord"},{"key":"2026070711162185300_bib41","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s13018-022-03293-0","article-title":"Platelet-rich plasma use in meniscus repair treatment: a systematic review and meta-analysis of clinical studies","volume":"17","author":"Li","year":"2022","journal-title":"J Orthop Surg Res"},{"key":"2026070711162185300_bib42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1055\/s-0040-1709170","article-title":"Efficacy of platelet-rich plasma for low back pain: a systematic review and meta-analysis","volume":"81","author":"Xuan","year":"2020","journal-title":"J Neurol Surg Cent Eur Neurosurg"},{"key":"2026070711162185300_bib43","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00590-019-02603-3","article-title":"Efficacy of platelet-rich plasma in posterior lumbar interbody fusion: systematic review and meta-analysis","volume":"30","author":"Pairuchvej","year":"2020","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"2026070711162185300_bib44","doi-asserted-by":"crossref","first-page":"604","DOI":"10.5435\/JAAOS-D-22-00808","article-title":"Orthobiologics: current status in 2023 and future outlook","volume":"31","author":"Rodeo","year":"2023","journal-title":"J Am Acad Orthop Surg"},{"key":"2026070711162185300_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/jeo2.12099","article-title":"Role of Orthobiologics in managing patellar tendinopathy: a narrative review","volume":"11","author":"Banerjee","year":"2024","journal-title":"J Exp Orthop"},{"key":"2026070711162185300_bib46","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s13770-023-00560-x","article-title":"Biotherapeutic applications of platelet-rich plasma in regenerative medicine","volume":"20","author":"Pineda-Cortel","year":"2023","journal-title":"Tissue Eng Regen Med"},{"key":"2026070711162185300_bib47","doi-asserted-by":"crossref","DOI":"10.1177\/23259671221101626","article-title":"Regulatory and ethical aspects of orthobiologic therapies","volume":"10","author":"Murray","year":"2022","journal-title":"Orthop J Sports Med"},{"key":"2026070711162185300_bib48","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1177\/03635465231207060","article-title":"Exosomes: the new kid on the block in Orthobiologics","volume":"51","author":"Rodeo","year":"2023","journal-title":"Am J Sports Med"},{"key":"2026070711162185300_bib49","first-page":"254","article-title":"\u201cGenetic scissors\u201d CRISPR\/Cas9 genome editing cutting-edge biocarrier technology for bone and cartilage repair","volume":"22","author":"Li","year":"2023","journal-title":"Bioact Mater"},{"key":"2026070711162185300_bib50","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jconrel.2024.11.057","article-title":"RNA therapies for musculoskeletal conditions","volume":"377","author":"Mancino","year":"2025","journal-title":"J Control Release"},{"key":"2026070711162185300_bib51","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13075-022-02969-6","article-title":"Individual immune cell and cytokine profiles determine platelet-rich plasma composition","volume":"25","author":"Niemann","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"2026070711162185300_bib52","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.joca.2024.02.073","article-title":"A single placenta-derived mesenchymal-like stromal cell injection halts progression of primary knee osteoarthritis \u2013 first preclinical results from the PROTO consortium","volume":"32","author":"Maleitzke","year":"2024","journal-title":"Osteoarthr Cartil"}],"container-title":["EFORT Open Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eor.bioscientifica.com\/view\/journals\/eor\/10\/6\/EOR-2025-0069.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eor.bioscientifica.com\/downloadpdf\/journals\/eor\/10\/6\/EOR-2025-0069.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/eor\/article-pdf\/10\/6\/345\/13766\/eor-2025-0069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/eor\/article-pdf\/10\/6\/345\/13766\/eor-2025-0069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:51:13Z","timestamp":1783439473000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/eor\/article\/10\/6\/345\/1851\/Evidence-based-guidelines-on-orthobiologics"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,2]]},"published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1530\/eor-2025-0069","relation":{},"ISSN":["2058-5241"],"issn-type":[{"value":"2058-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,1]]}}}